Literature DB >> 21796493

The critical care research networks experience.

P D Le Roux1, J Cooper, K K Guntupalli, R Silbergleit, J Daily, R Geocadin, C A C Wijman, J I Suarez.   

Abstract

Neurocritical care is a subspecialty of critical care medicine, dedicated to the care and the advancement of care of critically ill patients with neurosurgical or neurological diseases. Neurocritical care patients are heterogeneous, in both their disease process and the therapies they receive, however, several studies demonstrate that care of these patients in dedicated NeuroIntensive Care Units (neuroICUs) by neurointensivists, who coordinate their care is associated with reduced mortality and resource utilization. NeuroICUs foster innovation, and yet despite all the recent advances, much research needs to be undertaken in neurocritical care to better understand the disease pathophysiology and to demonstrate improved outcome with the use of goal-directed therapy based on evolving techniques and therapies.

Entities:  

Mesh:

Year:  2012        PMID: 21796493     DOI: 10.1007/s12028-011-9610-z

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  39 in total

1.  Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group.

Authors:  R Bellomo; M Chapman; S Finfer; K Hickling; J Myburgh
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

2.  A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients.

Authors:  James Dean Sandham; Russell Douglas Hull; Rollin Frederick Brant; Linda Knox; Graham Frederick Pineo; Christopher J Doig; Denny P Laporta; Sidney Viner; Louise Passerini; Hugh Devitt; Ann Kirby; Michael Jacka
Journal:  N Engl J Med       Date:  2003-01-02       Impact factor: 91.245

3.  Comparison of two fluid-management strategies in acute lung injury.

Authors:  Herbert P Wiedemann; Arthur P Wheeler; Gordon R Bernard; B Taylor Thompson; Douglas Hayden; Ben deBoisblanc; Alfred F Connors; R Duncan Hite; Andrea L Harabin
Journal:  N Engl J Med       Date:  2006-05-21       Impact factor: 91.245

4.  Delirium in the intensive care unit: an under-recognized syndrome of organ dysfunction.

Authors:  E W Ely; M D Siegel; S K Inouye
Journal:  Semin Respir Crit Care Med       Date:  2001       Impact factor: 3.119

5.  Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage.

Authors:  M N Diringer; D F Edwards
Journal:  Crit Care Med       Date:  2001-03       Impact factor: 7.598

6.  Impact of a neurointensivist on outcomes in patients with head trauma treated in a neurosciences intensive care unit.

Authors:  Panayiotis N Varelas; Dan Eastwood; Hyun J Yun; Marianna V Spanaki; Lotfi Hacein Bey; Christos Kessaris; Thomas A Gennarelli
Journal:  J Neurosurg       Date:  2006-05       Impact factor: 5.115

7.  Survival, quality of life, and charges in critically III surgical patients requiring prolonged ICU stays.

Authors:  S M Fakhry; K W Kercher; R Rutledge
Journal:  J Trauma       Date:  1996-12

8.  Tissue plasminogen activator for acute ischemic stroke.

Authors: 
Journal:  N Engl J Med       Date:  1995-12-14       Impact factor: 91.245

9.  Outcome after traumatic brain injury improved by an organized secondary insult program and standardized neurointensive care.

Authors:  Kristin Elf; Pelle Nilsson; Per Enblad
Journal:  Crit Care Med       Date:  2002-09       Impact factor: 7.598

10.  Impact of a specialized neurointensive care team on outcomes of critically ill acute ischemic stroke patients.

Authors:  Eric M Bershad; Eliahu S Feen; Olga H Hernandez; M Fareed K Suri; Jose I Suarez
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

View more
  1 in total

1.  Neurocritical Care Research Networks--pediatric considerations.

Authors:  Michael J Bell; Jose A Pineda; Monica S Vavilala; Mark S Wainwright; Allan Doctor; Rachel Stanley; Ann E Thompson
Journal:  Neurocrit Care       Date:  2012-12       Impact factor: 3.210

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.